LRRK2 and Parkinson disease: Nonetheless, GWAS indicate that Tau is also highly relevant to PD [113], with post-mortem Tau pathology having been reported in brains from PD patients harbouring pathogenic LRRK2 mutations [4, 114, 115] and in LRRK2 mouse models [116–118].